Lyme disease: Why early diagnosis is often missed

Lyme disease, or Lyme borreliosis, is the most common vector-borne illness in the Northern Hemisphere. The causative agent, Borrelia burgdorferi sensu lato, is a group of spirochetes transmitted to humans through the bite of infected Ixodes ticks. These ticks, often referred to as deer ticks or black-legged ticks, are prevalent in wooded and grassy areas, making outdoor activities a primary risk factor for exposure. The disease's clinical presentation is highly variable, evolving through distinct stages that can affect multiple organ systems, including the skin, joints, heart, and nervous system.

The disease typically progresses through three stages: early localized, early disseminated, and late disseminated. Each stage is characterized by a unique set of symptoms, though there can be overlap, and not all patients experience every stage or symptom. The incubation period from tick bite to the onset of symptoms can range from a few days to several weeks, influencing the initial clinical picture and diagnostic approach.

Understanding the Stages of Lyme Disease

The early localized stage is often marked by the pathognomonic erythema migrans (EM) rash, which appears in approximately 70-80% of infected individuals. This distinctive rash typically develops 3 to 30 days after the tick bite, expanding centrifugally from the bite site to form a characteristic 'bull's-eye' appearance, though it can also present as a more uniform red patch. The EM rash is usually asymptomatic, but some patients report warmth, itching, or a burning sensation. Accompanying symptoms can include fatigue, headache, myalgia, arthralgia, and low-grade fever, often non-specific and easily mistaken for a viral illness. The presence of EM, particularly in an endemic area, is sufficient for a clinical diagnosis and warrants immediate antibiotic treatment without waiting for serological confirmation.

If left untreated, the spirochetes can disseminate through the bloodstream and lymphatic system, leading to the early disseminated stage, which typically occurs weeks to months after the initial infection. This stage can manifest with a broader range of symptoms affecting various organ systems. Neurological manifestations, known as neuroborreliosis, can include lymphocytic meningitis, cranial neuropathies (most commonly facial palsy, which can be bilateral), and radiculoneuropathy. Cardiac involvement, or Lyme carditis, can present as atrioventricular block of varying degrees, myocarditis, or pericarditis. Musculoskeletal symptoms often include migratory arthralgias and intermittent arthritis, particularly affecting large joints like the knee. Multiple erythema migrans lesions can also appear at this stage, indicating widespread dissemination of the spirochetes. The severity and combination of these symptoms vary widely among patients, making diagnosis challenging without a clear history of tick exposure or prior EM.

The late disseminated stage can develop months to years after the initial infection if treatment is delayed or inadequate. The most common manifestation of late Lyme disease is Lyme arthritis, characterized by recurrent, brief attacks of objective joint swelling and pain, primarily in large joints, especially the knee. This arthritis can become chronic and destructive if not treated. Chronic neurological manifestations can include Lyme encephalopathy, presenting with subtle cognitive impairments such as memory loss, difficulty concentrating, and mood disturbances. Rarely, chronic radiculoneuropathy or polyneuropathy can occur. Acrodermatitis chronica atrophicans (ACA), a chronic skin manifestation, is more common in Europe and presents as reddish-blue discoloration and swelling, typically on the extremities, which later progresses to skin atrophy. The diagnosis of late Lyme disease often requires a combination of clinical suspicion, serological testing, and sometimes direct detection of spirochetes or their DNA in affected tissues or fluids.

Diagnostic Approaches and Challenges

Diagnosing Lyme disease relies on a combination of clinical evaluation and laboratory testing, but the interpretation of results can be complex, especially in early disease. The Centers for Disease Control and Prevention (CDC) and European guidelines recommend a two-tiered serological testing approach for suspected Lyme disease, particularly when EM is absent or atypical. The first step involves an enzyme immunoassay (EIA) or immunofluorescence assay (IFA) to detect antibodies against Borrelia burgdorferi. If this initial test is positive or equivocal, a Western blot (immunoblot) is performed to confirm the presence of specific antibodies. For IgG Western blot, at least five of ten specific bands must be present, while for IgM, two of three bands are required.

The utility of serological testing is highly dependent on the stage of infection. In the early localized stage, particularly within the first few weeks of infection, antibody production may not yet be detectable, leading to false-negative results. This is why a clinical diagnosis based on the presence of erythema migrans is essential for preventing disease progression, as delaying treatment to await seroconversion can allow the disease to progress. But a positive serology only indicates exposure to Borrelia burgdorferi and does not necessarily confirm active infection, as antibodies can persist for years after successful treatment. This can complicate the diagnosis of new infections or treatment failures.

Other diagnostic methods, such as PCR for direct detection of bacterial DNA, are generally not recommended for routine diagnosis of Lyme disease due to their low sensitivity in blood. PCR may be useful in specific circumstances, such as testing synovial fluid from patients with Lyme arthritis or cerebrospinal fluid in suspected neuroborreliosis, where the bacterial load might be higher. But even in these cases, a negative PCR does not rule out infection. Culture of Borrelia burgdorferi is technically challenging and time-consuming, making it impractical for routine clinical use. The Oxford Handbook of Infectious Diseases and Microbiology provides a comprehensive overview of these diagnostic complexities.

Prevention Strategies and Prophylaxis

Preventing Lyme disease primarily involves minimizing exposure to infected ticks. This includes avoiding wooded and bushy areas with high grass, especially during peak tick activity seasons (spring and summer). When outdoors, individuals should wear protective clothing, such as long-sleeved shirts and long trousers tucked into socks, and use insect repellents containing DEET or picaridin on exposed skin and clothing. Regular tick checks after spending time outdoors are essential. Ticks should be removed promptly and correctly using fine-tipped tweezers, grasping the tick as close to the skin surface as possible and pulling upward with steady, even pressure. Crushing or twisting the tick should be avoided, as this can increase the risk of pathogen transmission.

Post-exposure prophylaxis (PEP) with a single dose of doxycycline is recommended in specific situations. This typically applies to adults and children over 8 years of age who have sustained a high-risk tick bite, defined as an attached Ixodes scapularis tick that has been feeding for at least 36 hours, in an area where the incidence of Lyme disease is high. The doxycycline should be administered within 72 hours of tick removal. This prophylactic measure is not universally recommended for all tick bites, as the vast majority of bites do not result in Lyme disease, and widespread use of antibiotics could contribute to antimicrobial resistance. Careful patient selection based on risk factors is essential for effective prevention of infection.

Despite these measures, Lyme disease remains a challenge. The lack of a widely available human vaccine means that prevention relies heavily on individual vigilance and public health education. Continued research into more effective diagnostic tools, particularly for early infection, and novel prevention strategies is ongoing. For clinicians, maintaining a high index of suspicion, especially in endemic regions, and understanding the evolving clinical picture of Lyme disease are critical for timely diagnosis and appropriate management. The long-term consequences of untreated or inadequately treated Lyme disease, including chronic pain, fatigue, and neurological deficits, highlight the importance of early intervention.